November 6th 2024
Diego Torres-Russotto, MD, chair of neurology at Baptist Health Miami Neuroscience Institute, discussed the Miami Neuroscience Symposium’s focus on addressing the community’s neurological needs, balancing content delivery and fostering multidisciplinary collaboration.
Get direct access to expert insight and perspective, and all the coverage of the key data presentations, straight from the conference floor in Madrid.
Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis - Current Treatment and Emerging Con...
November 12, 2024
Register Now!
Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes
View More
2024 Neuromuscular Summit
November 20, 2024
View More
5th Annual International Congress on the Future of Neurology®
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Women's Neurology: An IJMSC Insights Conversation With Esther Bui, MD, FRCPC, and Riley Bove, MD
November 5th 2024A feature on NeurologyLive®, IJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).
REGISTER: Announcing the 2025 SEQUINS Annual Meeting on Brain Health Equity
November 5th 2024The multidisciplinary, 1-day scientific forum will be held May 15, 2025, in Charleston, South Carolina, focusing on nervous system health and care, and reducing neurological inequities and disparities.
Radiprodil in TSC and FCD: Targeting Seizures through NMDA Modulation
Bruce Leuchter, MD, president and chief executive officer at Neurvati Neurosciences, provided clinical insight on the newly initiated Astroscape trial of radiprodil for the treatment of tuberous sclerosis complex and focal cortical dysplasia type II.
The High Cost of Innovation: Navigating Rising Drug Prices in Neurology
Amy Tsou, MD, MSc, program director at the National Institutes of Neurological Disorders and Stroke, discussed the increasing cost of prescription drugs in the US and its impact on healthcare providers, including those who treat patients with neurologic conditions.
Alzheimer Agitation Therapy Brexpiprazole Maintains Safe Profile in Longitudinal Analysis
Over a 24-week period, comprising both the core study and extension trial, the incidence of treatment-emergent adverse events was infrequent, with less occurring over the long-term extension.
Lennox-Gastaut Syndrome: Unseen Challenges and the Need for Greater Awareness
Ahead of International LGS Awareness Day, Melanie Huntley, PhD, a data scientist for Roche and mother of child with Lennox-Gastaut syndrome, shed light on the realities of living with LGS, emphasizing the need for greater awareness of the condition’s impact.
Eisai Formally Submits BLA for Subcutaneous Autoinjector of Lecanemab
A subgroup analysis of the phase 3 Clarity AD open-label extension study showed a 14% increased amyloid plaque removal with subcutaneous lecanemab vs intravenous administration, the administration for which it was FDA-approved for.
Anti-Tau Agent E2814 Shows Impact on Early and Late Tau Biomarkers, Further Supporting Development
Despite a small cohort sample size, treated patients with E2814 demonstrated significant reductions in p-tau217 after 12 weeks of treatment, sustained through the 108-week time point.